Roberts C, Peters J, Sazonvos A, Goodman N, et al. Clinical Utility and Cost-Effectiveness of Pretreatment NUDT15 Pharmacogenetic Testing to Prevent Thiopurine-Induced Myelosuppression: A Genotype-First Reverse Phenotyping Cohort Study Within the UK NIHR Inflammatory Bowel Disease Bioresource. Aliment Pharmacol Ther 2025 Jun 23. doi: 10.1111/apt.70232.
PMID: 40548539